UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) July 27, 1998
-------------
NEOTHERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-28782 93-0979187
- -------------------------------------------------------------------------------
(State or other jurisdiction (Commission (IRS Employer
(of incorporation) File Number) Identification No.)
157 Technology Drive, Irvine, California 92618
-------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (949) 788-6700
--------------
Not Applicable
----------------------------------
(Former name or former address, if changed since last report)
(Telephone area code changed from (714) to (949)
Exhibit Index on Page 3
Page 1 of 5
Item 5. Other Events
Reference is made to the press release issued to the public by the
Registrant on July 27, 1998, the text of which is attached hereto as Exhibit
99.1, for a description of the events reported pursuant to this Form 8-K.
ITEM 7. EXHIBITS
EXHIBIT:
--------
99.1 PRESS RELEASE DATED JULY 27, 1998.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
NEOTHERAPEUTICS, INC.
Date: July 27, 1998 By: /s/ SAMUEL GULKO
-----------------------
Samuel Gulko
Chief Financial Officer
2
EXHIBIT INDEX
EXHIBITS DESCRIPTION
-------- -----------
99.1 Press Release dated July 27, 1998
3